# Alejandro E. De La Cruz, M.D. – FDA Inspection, Jul 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/alejandro-e-de-la-cruz-md/911f2eda-67b1-44b5-a8ff-106b9b4be2b1
Source feed: FDA_Inspections

> FDA inspection 1243870 of Alejandro E. De La Cruz, M.D., July 16, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243870
- Company Name: Alejandro E. De La Cruz, M.D.
- Inspection Date: 2024-07-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1264654 - 2025-03-18](https://www.keypedia.com/records/fda_inspections/alejandro-e-de-la-cruz-md/d88fcde6-992b-4bda-9de4-467547cb09de)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)

Company: https://www.keypedia.com/companies/alejandro-e-de-la-cruz-md/fdee514c-d525-4248-8a1c-2533495b6dbb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c